PDGFRA: A Protein Wound Healing Potential Drug Target (G5156)

Target Name: PDGFRA

NCBI ID: G5156

PDGFRA

PDGFRA: A Protein Wound Healing Potential Drug Target

PDGFRA (Platelet-derived growth factor receptor 2) is a protein that is found on the surface of certain cells in the body, including platelets, which are important for blood clotting. The PDGFRA protein is involved in many different processes in the body, including cell signaling, tissue repair, and regeneration.

One of the main functions of PDGFRA is to signal the growth and development of platelets. When a cell needs to divide,PDGFRA helps to regulate the cell's growth by stimulating the production of new plates, or platelets. This is important for maintaining blood clotting and for repairing damaged tissue.

PDGFRA is also involved in the process of wound healing. When a wound is injured,PDGFRA helps to stimulate the growth of new tissue and the formation of new blood vessels, which helps to repair the damaged tissue.

PDGFRA is also involved in cell signaling. It plays a role in the development and maintenance of tissues such as blood vessels, bones, and skin. It also helps to regulate the production of new cells in the body, including blood cells, which are important for maintaining the immune system.

PDGFRA is also a potential drug target. Researchers are studying the use of PDGFRA as a potential therapeutic agent for a variety of conditions, including cancer, cardiovascular disease, and neurodegenerative diseases.

One of the main advantages of PDGFRA as a drug target is its ability to be targeted to specific cells. This is because PDGFRA is only expressed on the surface of certain cells, such as platelets, and is not found in other cells in the body. This allows researchers to target the use of drugs to specific cells and to avoid potential side effects caused by targeting other cells.

Another advantage of PDGFRA as a drug target is its role in the development and maintenance of tissues. This means that drugs that target PDGFRA may be effective in treating conditions that are related to the development or maintenance of tissues, such as cancer, neurodegenerative diseases, and cardiovascular disease.

PDGFRA is also a potential biomarker for some diseases. This is because its levels can be easily measured and its levels may be affected by certain diseases. For example, PDGFRA levels may be affected by cancer, so if levels of PDGFRA are elevated in a patient with cancer, this may be a sign of the disease.

In conclusion, PDGFRA is a protein that is involved in many different processes in the body, including cell signaling, tissue repair, and regeneration. It is also a potential drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of PDGFRA in the body and its potential as a therapeutic agent.

Protein Name: Platelet Derived Growth Factor Receptor Alpha

Functions: Tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis. Depending on the context, promotes or inhibits cell proliferation and cell migration. Plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells. Required for normal skeleton development and cephalic closure during embryonic development. Required for normal development of the mucosa lining the gastrointestinal tract, and for recruitment of mesenchymal cells and normal development of intestinal villi. Plays a role in cell migration and chemotaxis in wound healing. Plays a role in platelet activation, secretion of agonists from platelet granules, and in thrombin-induced platelet aggregation. Binding of its cognate ligands - homodimeric PDGFA, homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFC -leads to the activation of several signaling cascades; the response depends on the nature of the bound ligand and is modulated by the formation of heterodimers between PDGFRA and PDGFRB. Phosphorylates PIK3R1, PLCG1, and PTPN11. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the activation of protein kinase C. Phosphorylates PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and thereby mediates activation of the AKT1 signaling pathway. Mediates activation of HRAS and of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3 and STAT5A and/or STAT5B. Receptor signaling is down-regulated by protein phosphatases that dephosphorylate the receptor and its down-stream effectors, and by rapid internalization of the activated receptor

The "PDGFRA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PDGFRA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets